← Back to Search

breath test for Non-Small Cell Lung Cancer

N/A
Waitlist Available
Led By Hossein Borghaei
Research Sponsored by Fox Chase Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 years
Awards & highlights

Study Summary

This trial is testing whether a nanoscale artificial nose can be used to monitor response and detect recurrence of NSCLC after surgery or radiation therapy.

Eligible Conditions
  • Non-Small Cell Lung Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percent of patients that become nanoscale artificial nose negative within 3 years post-surgery
Successful evaluation of gas samples taken from lung cancer patients
Secondary outcome measures
Lead time between the transition from nanoscale artificial nose negativity to positivity and clinical recurrence
Percentage of patients who become nanoscale artificial nose negative within 3 years and recur within that time frame that will become nanoscale artificial nose positive before recurrence
Time to become nanoscale artificial nose negative post treatment

Trial Design

1Treatment groups
Experimental Treatment
Group I: Treatment (NA-NOSE breath test)Experimental Treatment2 Interventions
Patients undergo breath sample collection for the NA-NOSE breath test at baseline (2 pre-treatment samples), and post-treatment samples at regularly scheduled follow up visits, for 2 years in the absence of disease progression.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
breath test
2012
N/A
~50

Find a Location

Who is running the clinical trial?

Fox Chase Cancer CenterLead Sponsor
227 Previous Clinical Trials
37,468 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,651 Previous Clinical Trials
40,932,889 Total Patients Enrolled
Hossein BorghaeiPrincipal InvestigatorFox Chase Cancer Center
3 Previous Clinical Trials
10,601 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there enrollment opportunities for this scientific experiment at present?

"According to the trial's listing on clinicaltrials.gov, it is no longer recruiting participants at this time. It was first posted back in August 2012 and its last update happened in October 2022 - yet there are still 2910 other studies welcoming patients right now."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Study to Evaluate NA-NOSE for Monitoring and Detecting Recurrence in Early Stage Lung Cancer
2012. "Study to Evaluate NA-NOSE for Monitoring and Detecting Recurrence in Early Stage Lung Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01840150.
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top